Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionprotein kinase activator activity

MOB3A MOB3C MOB3B

7.35e-04149243GO:0030295
GeneOntologyMolecularFunctionkinase activator activity

MOB3A MOB3C MOB3B

8.87e-04159243GO:0019209
GeneOntologyBiologicalProcessregulation of presynapse organization

MDGA1 NLGN3 FARP1

2.03e-0546243GO:0099174
GeneOntologyBiologicalProcesspresynapse assembly

MDGA1 NLGN3 FARP1

4.53e-0560243GO:0099054
GeneOntologyBiologicalProcesspresynapse organization

MDGA1 NLGN3 FARP1

8.16e-0573243GO:0099172
GeneOntologyBiologicalProcessprepulse inhibition

NLGN3 CHD8

2.43e-0420242GO:0060134
DomainMob1_phocein

MOB3A MOB3C MOB3B

6.50e-087243PF03637
DomainMOB_kinase_act_fam

MOB3A MOB3C MOB3B

6.50e-087243IPR005301
Domain-

MOB3A MOB3C MOB3B

6.50e-0872431.20.140.30
DomainMob1_phocein

MOB3A MOB3C MOB3B

6.50e-087243SM01388
DomainFerritin-like_SF

MOB3A MOB3C MOB3B

6.72e-0714243IPR009078
Pubmed

Molecular characterization of human homologs of yeast MOB1.

MOB3A MOB3C MOB3B

1.61e-08824319739119
Pubmed

DSCAM Deficiency Leads to Premature Spine Maturation and Autism-like Behaviors.

MDGA1 NLGN3

1.47e-042624234848499
CytobandXq13.1

GCNA NLGN3

2.91e-0448242Xq13.1
CytobandEnsembl 112 genes in cytogenetic band chrXq13

GCNA NLGN3

3.36e-03165242chrXq13
GeneFamilyMOB kinase activators|STRIPAK complex

MOB3A MOB3C MOB3B

3.43e-087193647
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L5-6_THEMIS_TMEM233|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

XYLT1 MDGA1 TTC6 RXFP2

2.42e-06179244747a32460b257fffca30527b56a74720eb9c12e4
Diseasecoronary aneurysm

MDGA1 ZNF618 TTC6

3.04e-0635243EFO_1000881
Diseasesusceptibility to rheumatic fever measurement

XYLT1 FARP1

2.37e-0428242EFO_0008416
Diseaseresponse to tenofovir

XYLT1 CHAMP1

7.89e-0451242EFO_0009279
DiseaseAutism Spectrum Disorders

NLGN3 CHD8

2.17e-0385242C1510586
DiseaseDrug Use Disorders

XYLT1 FARP1

3.93e-03115242C0013222
DiseaseDrug Dependence

XYLT1 FARP1

3.93e-03115242C1510472
DiseaseDrug habituation

XYLT1 FARP1

3.93e-03115242C0013170
DiseaseSubstance Dependence

XYLT1 FARP1

3.93e-03115242C0038580
DiseaseSubstance Use Disorders

XYLT1 FARP1

3.93e-03115242C0038586
DiseaseSubstance-Related Disorders

XYLT1 FARP1

3.93e-03115242C0236969
DiseaseDrug abuse

XYLT1 FARP1

3.93e-03115242C0013146
DiseaseOrganic Mental Disorders, Substance-Induced

XYLT1 FARP1

3.93e-03115242C0029231
DiseasePrescription Drug Abuse

XYLT1 FARP1

3.93e-03115242C4316881
DiseaseSubstance abuse problem

XYLT1 FARP1

4.00e-03116242C0740858
Diseaseautism spectrum disorder (implicated_via_orthology)

NLGN3 CHD8

6.75e-03152242DOID:0060041 (implicated_via_orthology)

Protein segments in the cluster

PeptideGeneStartEntry
VHCKQYYALEVSYFK

COPS5

216

Q92905
EEFFVKYKNYSYLHC

CHD8

666

Q9HCK8
WNKHSIYYCYHNFTF

CATSPERE

461

Q5SY80
YSYLFHCKYYAHLAV

ADCY10

1221

Q96PN6
HYYLLNYAKKCHQSE

BBS10

611

Q8TAM1
HVNTCYKHFYYFVTE

MOB3B

181

Q86TA1
FYCVSFFYHMYGKHI

MDGA1

831

Q8NFP4
AHVNTCYKHFYYFVK

MOB3A

181

Q96BX8
YYHFYHSKTFKRSTL

PCSK6

106

P29122
TYFYAFYHHCQSLMK

NLGN3

501

Q9NZ94
EYVKYAKPHFHYNNS

GSAP

531

A4D1B5
YVFKLHFKSHVYYFR

FARP1

996

Q9Y4F1
KCFFTSKMYSNVYYH

CHAMP1

66

Q96JM3
VATFSKHFYYQHNFF

GPR63

336

Q9BZJ6
TRCHNYKINYKVHYE

GCNA

631

Q96QF7
HVNTCYKHFYYFIRE

MOB3C

181

Q70IA8
FHYYHYGKFAEKYDS

PDIA5

476

Q14554
YFHEAYFKKHKFNTV

POMGNT1

511

Q8WZA1
HIYFKNFRYCSYAPH

RXFP2

381

Q8WXD0
FKAIYHKDHFYYIHV

XYLT1

346

Q86Y38
KYKYYSCFQEHRDLH

ZNF618

196

Q5T7W0
AVYFNRAHFYYCLKQ

TTC6

451

Q86TZ1
FNMYFYHYSKTQHSK

UBR1

831

Q8IWV7
KFFIMHHCASLYAYY

TLCD4

116

Q96MV1